600741

Teva Pharmaceuticals USA, Inc — FEI 3003092769

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 14, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Parsippany, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
202721 CFR 211.192Investigations of discrepancies, failures
202821 CFR 211.192Extent of discrepancy, failure investigations
358521 CFR 211.110(a)Control procedures to monitor and validate performance